# BioCircuit Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biocircuit-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Atlanta, US
- Website: www.biocircuit.com
- Total disclosed funding: $9M
- Latest round: Seed (Sep 27, 2022)
- Investors on record: 3

## About

Based in Georgia, US, and founded in 2016 by James Ross BioCircuit Technologies operates as a healthcare company that provides developing tools for neural interfacing and tissue repair. In September 2022, BioCircuit Technologies raised USD 9 million in seed funding led by Masters Capital, with participation from Alsora Capital and GRA Venture Fund Other investors also participated in the round. As of October 2022, Michelle Jarrard is the Chief Operating Officer (CEO) of the company. 

BioCircuit Technologies monitors, control, and repair nerves consistently. The company's devices use multi-electrode arrays and proprietary algorithms to repair peripheral nerves while also allowing clinicians to diagnose health conditions, track symptoms, and correctly select treatments for patients.

The company intends to use the funds to commercialize its nerve repair device, Nerve Tape®, and develop its therapeutic device and a variety of other neurological conditions.

## Funding rounds

- Seed, Sep 27, 2022, $9M — Masters Capital, GRA Venture Fund, Alsora Capital

## Investors

- Masters Capital — Seed
- GRA Venture Fund (https://capitalatlas.ai/funds/gra-venture-fund) — Seed
- Alsora Capital (https://capitalatlas.ai/funds/alsora-capital) — Seed